Dormant Therapy - PDFSEARCH.IO - Document Search Engine

Dormant Therapy
Results: 8

#	Item
1	National Health Council 1730 M Street NW, Suite 500, Washington, DC[removed] ■ [removed] ■ www.nationalhealthcouncil.org ■ [removed] Response to Request for Information on the Strategy for American In Add to Reading List Source URL: www.nationalhealthcouncil.org Language: English - Date: 2014-12-16 12:43:21 MODDERN Cures Act Biosimilar Food and Drug Administration Pharmaceutical industry Clinical trial Dormant Therapy Drug Price Competition and Patent Term Restoration Act Pharmaceutical drug Patient safety organization Pharmaceutical sciences Pharmacology Clinical research
2	Modernizing Our Drug & Diagnostics Evaluation and Regulatory Network: The MODDERN Cures Act More than 133 million Americans – over 40% the U.S. population – live with a chronic disease or disability. For many people Add to Reading List Source URL: www.nationalhealthcouncil.org Language: English - Date: 2014-12-16 12:49:19 Medicine MODDERN Cures Act Personalized medicine Food and Drug Administration Dormant Therapy Biologic Alternative medicine Pharmaceutical drug Test data exclusivity Pharmacology Pharmaceutical sciences Clinical research
3	Testimony of Marc Boutin, JD Executive Vice President and Chief Operating Officer National Health Council 21st Century Cures Initiative Hearing - June 11, 2014 House Committee on Energy and Commerce Add to Reading List Source URL: www.nationalhealthcouncil.org Language: English - Date: 2014-12-16 12:49:40 Health Clinical pharmacology Drug discovery Pharmaceuticals policy MODDERN Cures Act Pharmaceutical industry Dormant Therapy Orphan drug Food and Drug Administration Pharmaceutical sciences Pharmacology Clinical research
4	National Health Council 1730 M Street NW, Suite 500, Washington, DC[removed] ■ [removed] ■ www.nationalhealthcouncil.org ■ [removed] Response to Request for Information on the Strategy for American In Add to Reading List Source URL: stg.nhc.newtarget.net Language: English - Date: 2014-10-31 09:11:05 MODDERN Cures Act Biosimilar Food and Drug Administration Pharmaceutical industry Clinical trial Dormant Therapy Drug Price Competition and Patent Term Restoration Act Pharmaceutical drug Patient safety organization Pharmaceutical sciences Pharmacology Clinical research
5	National Health Council 1730 M Street NW, Suite 500, Washington, DC[removed] ■ [removed] ■ www.nationalhealthcouncil.org ■ [removed] Response to Request for Information on the Strategy for American In Add to Reading List Source URL: www.nationalhealthcouncil.org Language: English - Date: 2014-09-24 14:06:41 MODDERN Cures Act Biosimilar Food and Drug Administration Pharmaceutical industry Clinical trial Dormant Therapy Drug Price Competition and Patent Term Restoration Act Pharmaceutical drug Patient safety organization Pharmaceutical sciences Pharmacology Clinical research
6	Testimony of Marc Boutin, JD Executive Vice President and Chief Operating Officer National Health Council 21st Century Cures Initiative Hearing - June 11, 2014 House Committee on Energy and Commerce Add to Reading List Source URL: www.nationalhealthcouncil.org Language: English - Date: 2014-06-10 11:16:34 Health Clinical pharmacology Drug discovery Pharmaceuticals policy MODDERN Cures Act Pharmaceutical industry Dormant Therapy Orphan drug Food and Drug Administration Pharmaceutical sciences Pharmacology Clinical research
7	Testimony of Marc Boutin, JD, Executive Vice President and Chief Operating Officer of the National Health Council 21st Century Cures Initiative Hearing - June 11, 2014 House Committee on Energy and Commerce June 9, 2014 Add to Reading List Source URL: docs.house.gov Language: English - Date: 2014-06-09 15:29:45 Health Clinical pharmacology Drug discovery Pharmaceuticals policy MODDERN Cures Act Pharmaceutical industry Dormant Therapy Orphan drug Food and Drug Administration Pharmaceutical sciences Pharmacology Clinical research
8	Testimony of Marc Boutin, JD Executive Vice President and Chief Operating Officer National Health Council 21st Century Cures Initiative Hearing - June 11, 2014 House Committee on Energy and Commerce Add to Reading List Source URL: www.nationalhealthcouncil.org Language: English - Date: 2014-06-11 11:20:35 Health Clinical pharmacology Drug discovery Pharmaceuticals policy MODDERN Cures Act Pharmaceutical industry Dormant Therapy Orphan drug Food and Drug Administration Pharmaceutical sciences Pharmacology Clinical research